Media
News and press releases
Welcome to our media section. Check out the latest news and press releases from Cinclus Pharma and don’t hesitate to contact us if you need more information.
Latest pressreleases
Latest News
Cinclus Pharma at ABGSC - Life Science Summit 2023
Christer Ahlberg, CEO of Cinclus Pharma, was invited to present the company's latest updates and the development of linaprazan glurate at the ABGSC Life Science Summit on May 30-31, 2023.
Nina Rawal at Trill Impact Ventures on the investment in Cinclus Pharma
The Investment company Trill Impact sees Cinclus Pharma as a strong card. Nina Rawal, Co-Head of Ventures, sits on the board of Cinclus Pharma, where her biomedical experience and expertise in financing comes in handy.
Malin Filler – Senior Regulatory Affairs Manager
The stimulating role as Regulatory Affairs Manager at Cinclus Pharma fits Malin like a glove. She is currently working intensively to prepare all regulatory activities required for the start of the phase III program for the drug...
Kajsa Larsson - experienced CMO with a focus on patient safety
Chief Medical Officer Kajsa Larsson is a licensed physician specializing in hematology and internal medicine with clinical and industry experience. She also has a Ph.D. in Medicine. With great commitment and focus on patient....
Cinclus Pharma in media
New research advances for Linc-owned pharmaceutical company
2022-11-04[Swedish link] Cinclus Pharma har presenterat positiva resultat i en fas 2-studie kring en behandling av magsyrarelaterade besvär.
Cinclus Pharma raises a quarter of a billion SEK - EQT founder among investors
2022-05-20|Swedish link] Cinclus Pharma tar in nära en kvarts miljard kronor i en riktad emission inför bolagets stundande börsnotering. Riskkapitalfonden Eir...
Cinclus raises 240 million for Losec follow-up
2022-05-20[Swedish link] Cinclus Pharma tar in cirka 240 miljoner kronor i en nyemission. Målet: att ta fram en uppföljare till magsårsläkemedlen Losec och Nexium...
Telegram: Bengt Julanders Linc invests in Cinclus Pharma
2022-05-20[Swedish link] Forskningsbolaget Cinclus Pharma genomför en kapitalanskaffning där bolaget tar in cirka 240 miljoner ...
Telegram: Cinclus Pharma raises SEK 240 million
2022-05-20[Swedish link] Cinclus Pharma, ett biofarmaceutiskt företag, har rest cirka 240 miljoner kronor genom en riktad nyemission. Syftet är att anskaffa ...
